FDA Amends Regulations to Protect Reporters of Adverse Events and Patients' Identities

Summary

The FDA is updating its rules to safeguard the identities of individuals reporting adverse events related to FDA-regulated products and patients, preventing disclosure by the agency or manufacturers, and preempting state and local laws requiring such disclosure.